Bruce E. Maryanoff
Janssen Pharmaceutica
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bruce E. Maryanoff.
Tetrahedron Letters | 1989
Bruce E. Maryanoff; Allen B. Reitz; David W. Graden; Harold R. Almond
Abstract The fate of intermediate oxaphosphetanes in the reaction of t -BuCHO and Bu 3 PCHPr was monitored with time. Cis oxaphosphetane 1a was converted to trans oxaphosphetane 1b at −55 °C with k 3 = 1.5 ⊚ 10 −4 s −1 , and 1b was converted to Bu 3 PO and alkene 2b at −15 °C with k 6 = 2.7 ⊚ 10 −5 s −1 (t 1 2 = 7.0 h).
Tetrahedron Letters | 1988
Bruce E. Maryanoff; David F. McComsey; Martin S. Mutter; Kirk L. Sorgi; Cynthia A. Maryanuff
Abstract Either diastereomer of 2 or 10 is deoxygenated with BH 3 -THF/CF 3 CO 2 H to give mainly the trans product, 3b or 11b . The process involves a key enammonium-iminium rearrangement in which there is almost exclusive proton delivery from a single face.
Archive | 1992
Michael J. Costanzo; Bruce E. Maryanoff
Current Medicinal Chemistry | 2006
Bruce E. Maryanoff; William A. Kinney; Edward C. Lawson; Diane K. Luci; Shyamali Ghosh
Archive | 1993
Michael J. Costanzo; Bruce E. Maryanoff
Archive | 2003
Han-Cheng Zhang; Bruce E. Maryanoff; Hong Ye; Bruce R. Conway; Keith T. Demarest
Archive | 2005
David F. McComsey; Michael H. Parker; Allen B. Reitz; Bruce E. Maryanoff
Archive | 2009
Han-Cheng Zhang; Gee-Hong Kuo; Bruce E. Maryanoff; Hong Ye; David John O'Neill; Lan Shen; Keith T. Demarest; Bruce R. Conway; David F. McComsey
Journal of Medicinal Chemistry | 2007
Michael N. Greco; Michael J. Hawkins; Eugene Powell; Harold R. Almond; L. de Garavilla; J Hall; Lisa Minor; Yuanping Wang; Thomas W. Corcoran; E. Di Cera; Angelene M. Cantwell; Savvas N. Savvides; Bruce P. Damiano; Bruce E. Maryanoff
Archive | 2003
Ahmed F. Abdel-Magid; Cynthia A. Maryanoff; Steven J. Mehrman; Kirk L. Sorgi; Frank J. Villani; Cheryl P. Kordik; Allen B. Reitz; Bruce E. Maryanoff